🔗 Share this article

This year's Nobel Prize in medical science has been granted for transformative findings that clarify how the immune system targets dangerous infections while protecting the body's own cells.

A trio of esteemed researchers—Japan's Shimon Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—share this honor.

Their work identified specialized "security guards" within the defense system that remove malfunctioning immune cells capable of harming the organism.

These discoveries are now paving the way for innovative treatments for immune disorders and cancer.

The laureates will divide a prize fund worth 11 million Swedish kronor.

Decisive Discoveries

"Their work has been essential for comprehending how the body's defenses functions and why we don't all suffer from serious self-attack conditions," stated the chair of the Nobel Committee.

This team's research address a fundamental question: In what way does the immune system protect us from numerous invaders while keeping our own tissues intact?

Our immune system employs white blood cells that scan for indicators of infection, including pathogens and bacteria it has never encountered.

These cells utilize sensors—known as recognition units—that are generated randomly in a vast number of combinations.

That provides the immune system the capacity to combat a wide array of invaders, but the unpredictability of the mechanism inevitably creates white blood cells that can attack the host.

Protectors of the Immune System

Scientists previously understood that a portion of these problematic defense cells were destroyed in the immune organ—the site where white blood cells develop.

This year's Nobel Prize honors the identification of regulatory T-cells—known as the immune system's "security guards"—which patrol the system to disarm any defenders that assault the body's own tissues.

It is known that this mechanism malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

A prize committee stated, "These discoveries have established a new field of investigation and spurred the development of new treatments, for example for cancer and immune disorders."

Regarding malignancies, regulatory T-cells block the system from attacking the tumor, so research are focused on lowering their quantity.

In self-attack disorders, trials are exploring increasing T-reg cells so the body is no longer under attack. A comparable method could also be effective in minimizing the risks of organ transplant failure.

Pioneering Experiments

Prof Shimon Sakaguchi, from a Japanese institution, performed tests on mice that had their immune gland removed, causing autoimmune disease.

He demonstrated that introducing defense cells from healthy animals could prevent the illness—implying there was a system for blocking immune cells from attacking the body.

Mary Brunkow, from the a research center in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were investigating an genetic immune disorder in mice and humans that led to the discovery of a genetic factor critical for the way T-regs operate.

"The pioneering work has uncovered how the body's defenses is kept in check by regulatory T cells, stopping it from accidentally targeting the body's own tissues," commented a prominent biological science specialist.

"The work is a striking illustration of how basic biological study can have broad consequences for human health."